Search
Cerebral Cavernous Malformation Treatments Relieve Disparate Symptoms
Two patients with severe yet different neurological symptoms were referred to UCSF for emergent neurosurgical evaluation. Both were found to have previously undiagnosed cerebral cavernous malformations (CCMs), but each patient’s treatment was unique.First “Neuroprosthesis” Expands Vocabulary and Mobility for Man With Paralysis in New Milestone
The first “neuroprosthesis,” developed by UCSF researchers in 2021, translates brain signals from a man with severe paralysis directly into words that appear as text on a screen. Using this brain-machine interface, he can also move a robotic arm to manipulate objects.Novel Metabolic Imaging Method Detects Prostate Cancer Aggressiveness
UCSF investigators have shown that adding an emerging metabolic imaging technique to MR–transrectal ultrasound fusion prostate biopsies makes it possible to detect the extent and aggressiveness of prostate cancer more accurately than ever.Cardiology Transfer Guide
Cardiology Transfer GuideUCSF Health Transfer Center Intake Workflow
UCSF Health Transfer Center Intake WorkflowUCSF Researchers Uncover New Pathway for Molecular Cancer Drug Therapies
In a study published December 8, 2022 in Science, UCSF researchers Kevin Lou, an MD-PhD student, Luke Gilbert, PhD, and Kevan Shokat, PhD, reveal the discovery of a cellular uptake pathway important for larger molecules.International Conference Features UCSF Breast Cancer Experts
Breast cancer experts from UCSF Health presented new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference.International Hematologic Conference Features UCSF Health Experts
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.Alan P. Venook, MD, Recognized With Luminary Award for Gastrointestinal Cancers
Alan P. Venook, MD, a renowned expert in colorectal and liver cancers, has been announced as one of the winners of the 2022 Luminary Awards in Gastrointestinal (GI) Cancers.Rethinking How Cancer Cells Evade Targeted Therapy
Glioblastomas (GBMs) are incurable brain tumors with a prognosis of about one-and-a half years on average. They are highly resistant to treatment and have defied all attempts at precision therapy.UCSF Research Instrumental in Approval of Breakthrough Diabetes Therapy
The US Food and Drug Administration (FDA) recently approved the use of a new drug Teplizumab, an immunotherapy drug which has been shown to significantly delay the onset of type 1 diabetes.UCSF Researchers Develop Prediction Model of Aortic Aneurysm
Ascending thoracic aortic disease is an important cause of sudden death in the U.S., yet most aortic aneurysms are identified incidentally.UCSF Health Reaches 20,000 Organ Transplants
UC San Francisco surgeons have performed the health system’s 20,000th solid organ transplant, making it just the third in the nation to reach that milestone.Advanced Heart Failure Comprehensive Care Center Physician Pocket Card
Referral guide and contact information for advanced heart failure specialists at UCSF.Migraine Sufferers Are Prone to BPPV at an Earlier Age, Study Finds
Migraine predisposes individuals to developing benign paroxysmal positional vertigo (BPPV) earlier in life than those without migraine, according to a UCSF study.Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer
Tumor Immune Microenvironments May Provide Clues to Future TherapiesCerebrovascular Neurosurgery
As one of the highest volume and most experienced surgical programs in the nation for cerebrovascular disorders, we offer a wide range of treatment options tailored to each patient, leading to safer surgeries and better outcomes.Screening and Removal of Precancerous Lesions Prevents Anal Cancer
National study led by UCSF is first to show effectiveness of simple strategies to reduce risk of often silent cancer.UCSF Sheds Light on the Reasons Behind Sex Differences in Myocarditis
This study suggests mechanisms behind why myocarditis associated with cancer immunotherapies may occur more frequently in female patients.UCSF Surgeons Perform First Pure Robotic Whipple Surgery in the Bay Area
Gastrointestinal surgeons at UC San Francisco have performed the first pure robotically assisted Whipple surgery in San Francisco.UCSF Launches Initiative to Address Disparities in Pulse Oximetry Performance
This project seeks to improve accuracy for patients with darker skin pigmentation.UCSF Develops First of Its Kind Robotic Surgery Trial in Partnership with FDA
UCSF Health is recruiting patients for the only FDA-approved study of the use of single port robotic technology for colorectal surgery in the United States.Advanced Heart Failure Comprehensive Care Center
The Advanced Heart Failure Comprehensive Care Center (AHF CCC) at UCSF offers coordinated and comprehensive care for heart failure patients.The First Patient-Centered Sialadenitis Assessment Tool
A new standardized measure of symptoms associated with salivary duct obstruction was recently developed by researchers, including UCSF otolaryngologists Jolie Chang, MD, FACS, and William R. Ryan, MD, FACS, and UCSF medical student Arushi Gulati.